Literature DB >> 11565727

Modified button-Bentall operation for aortic root replacement: the miniskirt technique.

G Michielon1, L Salvador, U Da Col, C Valfrè.   

Abstract

BACKGROUND: The aim of this study was to evaluate the midterm results of a modified button-Bentall operation (modified-bB) specifically designed to incorporate any type of prosthetic valve in composite conduit aortic root replacement.
METHODS: Between 1991 and 2000, a total of 135 patients underwent modified-bB for annuloaortic ectasia (74 patients), type A dissection (31), or aortic aneurysm without dissection (30). Of these, 34 were emergencies (25.2%). A total of 50 bioprostheses (study group 1) and 85 bileaflet mechanical prostheses (study group 2) were implanted. Group 1 mean age was 66.9 +/- 7.4 years versus 51.5 +/- 12.1 years in group 2 (p < 0.001). Composite-conduit creation occurred during proximal suture line construction as a single-step maneuver. Interrupted extracardiac polyester mattress sutures sequentially entered the aortic annulus, the prosthetic valve ring, and the vascular graft 7 mm from its free edge (miniskirt). Running monofilament suture line secured proximal hemostasis, buttressing aortic remnants and graft edge. Coronary reimplantation was accomplished in all cases by the button technique. Concomitant procedures were performed in 51 patients (37.8%).
RESULTS: The 30-day mortality was 5.18% (7/135 patients). Eight patients (5.9%) required revision for proximal (1 patient), coronary button (3), or distal (4) anastomosis leakage. Three patients (2.2%) perioperatively developed nonfatal inferior myocardial infarction. Kaplan-Meier 9-year survival is 91.8% +/- 0.026 SE with 88.1% (95% confidence limits 71.7% to 95.5%) reoperation freedom. According to the Cox proportional hazard method, stratification of the risk for death according to prosthesis type indicates previous operation (p = 0.001) and emergency (p = 0.0465) as independent predictors of hospital mortality. Associated procedures to modified-bB increased risk of reoperation (p = 0.031).
CONCLUSIONS: Modified-bB was associated with low mortality, excellent midterm survival, and freedom from reoperation. Absence of valve-to-graft tapering, reduced coronary button anastomosis tension, and prosthesis selection according to patient profile, are apparent advantages of modified-bB.

Entities:  

Mesh:

Year:  2001        PMID: 11565727     DOI: 10.1016/s0003-4975(01)02975-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  A safer technique of aortic root replacement after aortic valve replacement.

Authors:  Masaru Yoshikai; Tsuyoshi Ito; Hiroyuki Ohnishi; Keiji Kamohara; Hideyuki Fumoto; Akira Furutachi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Modification of the Bentall operation using the proximal double sewing technique without excision of leaflets.

Authors:  Toshihiko Shibata; Kazushige Inoue; Takeshi Ikuta; Yoshiteru Yoshioka; Yasuyuki Bito; Hiroki Mizokuchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-08-13

3.  Hemostatic modifications of the Bentall procedure: imbricated proximal suture and fibrin sealant reduce postoperative morbidity and mortality rates.

Authors:  Alessandro Della Corte; Francesco Baldascino; Francesca La Marca; Michelangelo Scardone; Gianantonio Nappi; Mariano Cefarelli; Luca S De Santo; Paolo Pepino; Maurizio Cotrufo; Marisa De Feo
Journal:  Tex Heart Inst J       Date:  2012

4.  Intimal Detachment of the Left Main Coronary Artery in a Marfan Patient with Acute Aortic Dissection: An Alternative Technique for Coronary Revascularization.

Authors:  Joon Young Song; Tae Youn Kim; Jong Bum Choi; Ja Hong Kuh
Journal:  J Card Surg       Date:  2016-04-12       Impact factor: 1.620

5.  Simplified surgical approach to improve surgical outcomes in the center with a small volume of acute type A aortic dissection surgery.

Authors:  Jong Hun Kim; Jong Bum Choi; Tae Youn Kim; Kyung Hwa Kim; Ja Hong Kuh
Journal:  Technol Health Care       Date:  2018       Impact factor: 1.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.